Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Health

>> PFIZER Latest News

OCT 23, 2014 - Yahoo! News

A Must Read - Share

U.S. court upholds patents on Pfizer's cancer drug

(Reuters) - A U.S. district court ruled in favor of Pfizer Inc in a patent lawsuit it filed against Mylan Inc alleging patent infringement on its cancer drug, Sutent, Pfizer said. Pfizer filed the lawsuit in June 2010 after Mylan attempted to market a generic version of Sutent, patented until 2021. Sutent, which is approved for use in advanced kidney ...

Tags: U.S. court upholds patents on Pfizer's cancer drug,  Pfizer Latest News

OCT 17, 2014 - Washington Times

A Must Read - Share

Anti-abuse label approved for painkiller Embeda

The U.S. Food and Drug Administration says it has approved new labeling for another opioid designed to limit painkiller abuse. The FDA said Friday that Pfizer Inc.'s Embeda can have labeling indicating that it has properties expected to reduce abuse of the drug when it is crushed and ...

Tags: Anti-abuse label approved for painkiller Embeda,  Pfizer Latest News

OCT 17, 2014 - Fox News

A Must Read - Share

FDA panel votes to keep severe warning on Pfizer anti-smoking drug

Pfizer Inc failed to convince the U.S. Food and Drug Administration to remove a black box warning on its controversial quit-smoking drug Chantix, with an advisory panel to the agency voting against the removal on Thursday.

Tags: FDA panel votes to keep severe warning on Pfizer anti-smoking drug,  Pfizer Latest News

OCT 16, 2014 - Reuters

A Must Read - Share

FDA votes to keep black box warning on Pfizer anti-smoking drug

(Reuters) - Pfizer Inc failed in its attempt to remove a black box warning from its controversial quit-smoking drug, Chantix, after an advisory panel to the U.S. Food and Drug Administration voted against the removal.

Tags: FDA votes to keep black box warning on Pfizer anti-smoking drug,  Pfizer Latest News

OCT 16, 2014 - St. Louis Post-Dispatch

A Must Read - Share

FDA: little evidence to drop Chantix boxed warning

WASHINGTON • Federal regulators say Pfizer has provided low-quality evidence to support its request to remove a bold-letter warning from its anti-smoking drug Chantix about suicidal behavior.

Tags: FDA: little evidence to drop Chantix boxed warning,  Pfizer Latest News